Ontology highlight
ABSTRACT:
SUBMITTER: Pettit K
PROVIDER: S-EPMC4677344 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
Pettit Kristen K Odenike Olatoyosi O
Frontiers in oncology 20151214
Although acute myeloid leukemia (AML) is primarily a disease of older adults (age ≥60 years), the optimal treatment for older adults remains largely undefined. Intensive chemotherapy is rarely beneficial for frail older adults or those with poor-risk disease, but criteria that define fitness and/or appropriateness for intensive chemotherapy remain to be standardized. Evaluation of disease-related and patient-specific factors in the context of clinical decision making has therefore been largely s ...[more]